Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Patrick McGrath

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Devices

Placebos

Procedures

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Wisniewski Stephen R; Rush A John; Nierenberg Andrew A; Gaynes Bradley N; Warden Diane; Luther James F; McGrath Patrick J; Lavori Philip W; Thase Michael E; Fava Maurizio; Trivedi Madhukar H
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
Howland Robert H; Rush A John; Wisniewski Stephen R; Trivedi Madhukar H; Warden Diane; Fava Maurizio; Davis Lori L; Balasubramani G K; McGrath Patrick J; Berman Susan R
Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
McGrath Patrick J; Khan Ahsan Y; Trivedi Madhukar H; Stewart Jonathan W; Morris David W; Wisniewski Stephen R; Miyahara Sachiko; Nierenberg Andrew A; Fava Maurizio; Rush John A
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Patrick McGrath (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Wisniewski Stephen R; Rush A John; Nierenberg Andrew A; Gaynes Bradley N; Warden Diane; Luther James F; McGrath Patrick J; Lavori Philip W; Thase Michael E; Fava Maurizio; Trivedi Madhukar H
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
The American journal of psychiatry 2009;166(5):599-607.
2009: Howland Robert H; Rush A John; Wisniewski Stephen R; Trivedi Madhukar H; Warden Diane; Fava Maurizio; Davis Lori L; Balasubramani G K; McGrath Patrick J; Berman Susan R
Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Drug and alcohol dependence 2009;99(1-3):248-60.
2008: McGrath Patrick J; Khan Ahsan Y; Trivedi Madhukar H; Stewart Jonathan W; Morris David W; Wisniewski Stephen R; Miyahara Sachiko; Nierenberg Andrew A; Fava Maurizio; Rush John A
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
The Journal of clinical psychiatry 2008;69(12):1847-55.
2008: Stewart Jonathan W; Deliyannides Deborah A; McGrath Patrick J
Is duloxetine effective treatment for depression with atypical features?
International clinical psychopharmacology 2008;23(6):333-6.
2008: Bruder Gerard E; Sedoruk James P; Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M; Tenke Craig E
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.
Biological psychiatry 2008;63(12):1171-7.
2008: Gaynes Bradley N; Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Balasubramani G K; McGrath Patrick J; Thase Michael E; Klinkman Michael; Nierenberg Andrew A; Yates William R; Fava Maurizio
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
Journal of general internal medicine 2008;23(5):551-60.
2007: Bruder Gerard E; Stewart Jonathan W; Schaller Jennifer D; McGrath Patrick J
Predicting therapeutic response to secondary treatment with bupropion: dichotic listening tests of functional brain asymmetry.
Psychiatry research 2007;153(2):137-43.
2007: Wisniewski Stephen R; Fava Maurizio; Trivedi Madhukar H; Thase Michael E; Warden Diane; Niederehe George; Friedman Edward S; Biggs Melanie M; Sackeim Harold A; Shores-Wilson Kathy; McGrath Patrick J; Lavori Philip W; Miyahara Sachiko; Rush A John
Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
The American journal of psychiatry 2007;164(5):753-60.
2007: Thase Michael E; Friedman Edward S; Biggs Melanie M; Wisniewski Stephen R; Trivedi Madhukar H; Luther James F; Fava Maurizio; Nierenberg Andrew A; McGrath Patrick J; Warden Diane; Niederehe George; Hollon Steven D; Rush A John
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
The American journal of psychiatry 2007;164(5):739-52.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Stewart Jonathan W; Warden Diane; Niederehe George; Thase Michael E; Lavori Philip W; Lebowitz Barry D; McGrath Patrick J; Rosenbaum Jerrold F; Sackeim Harold A; Kupfer David J; Luther James; Fava Maurizio
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
The American journal of psychiatry 2006;163(11):1905-17.
2006: McGrath Patrick J; Stewart Jonathan W; Quitkin Frederic M; Chen Ying; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio; Cheng Jianfeng; Petkova Eva
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
The American journal of psychiatry 2006;163(9):1542-8.
2006: McGrath Patrick J; Stewart Jonathan W; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Thase Michael E; Davis Lori; Biggs Melanie M; Shores-Wilson Kathy; Luther James F; Niederehe George; Warden Diane; Rush A John
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1531-41; quiz 1666.
2006: Nierenberg Andrew A; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Thase Michael E; McGrath Patrick J; Alpert Jonathan E; Warden Diane; Luther James F; Niederehe George; Lebowitz Barry; Shores-Wilson Kathy; Rush A John
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1519-30; quiz 1665.
2006: Davis Lori L; Frazier Elizabeth; Husain Mustafa M; Warden Diane; Trivedi Madhukar; Fava Maurizio; Cassano Paolo; McGrath Patrick J; Balasubramani G K; Wisniewski Stephen R; Rush A John
Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR*D cohort.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2006;15(4):278-85.
2006: Fava Maurizio; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Alpert Jonathan E; McGrath Patrick J; Thase Michael E; Warden Diane; Biggs Melanie; Luther James F; Niederehe George; Ritz Louise; Trivedi Madhukar H
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
The American journal of psychiatry 2006;163(7):1161-72.
2006: Taylor Bonnie P; Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Halperin Jeffrey; Ehrlichman Howard; Quitkin Frederic M
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.
The American journal of psychiatry 2006;163(1):73-8.
2006: Rabkin Judith G; McElhiney Martin C; Rabkin Richard; McGrath Patrick J; Ferrando Stephen J
Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS.
The American journal of psychiatry 2006;163(1):59-66.
2006: Trivedi Madhukar H; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Warden Diane; Ritz Louise; Norquist Grayson; Howland Robert H; Lebowitz Barry; McGrath Patrick J; Shores-Wilson Kathy; Biggs Melanie M; Balasubramani G K; Fava Maurizio;
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
The American journal of psychiatry 2006;163(1):28-40.
2005: Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W; Deliyannides Deborah; Taylor Bonnie P; Davies Carrie A; Klein Donald F
Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients.
The Journal of clinical psychiatry 2005;66(6):670-6.
2005: Stewart Jonathan W; Quitkin Frederic M; McGrath Patrick J; Klein Donald F
Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
Journal of affective disorders 2005;86(2-3):161-7.
2005: Taylor Bonnie P; Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W
Do antihypertensives make tranylcypromine safer? Three case reports.
The Journal of clinical psychiatry 2005;66(5):657-8.
2005: Davis Lori L; Rush John A; Wisniewski Stephen R; Rice Kayla; Cassano Paolo; Jewell Michele E; Biggs Melanie M; Shores-Wilson Kathy; Balasubramani G K; Husain Mustafa M; Quitkin Frederic M; McGrath Patrick J
Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
Comprehensive psychiatry 2005;46(2):81-9.
2004: Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Deliyannides Deborah; Quitkin Frederic M
Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(9):1752-61.
2004: Rush A John; Fava Maurizio; Wisniewski Stephen R; Lavori Philip W; Trivedi Madhukar H; Sackeim Harold A; Thase Michael E; Nierenberg Andrew A; Quitkin Frederic M; Kashner T Michael; Kupfer David J; Rosenbaum Jerrold F; Alpert Jonathan; Stewart Jonathan W; McGrath Patrick J; Biggs Melanie M; Shores-Wilson Kathy; Lebowitz Barry D; Ritz Louise; Niederehe George;
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2003: Fava Maurizio; McGrath Patrick J; Sheu Wang-Pui;
Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine.
Journal of clinical psychopharmacology 2003;23(4):365-9.
2003: Stewart Jonathan W; Bruder Gerard E; McGrath Patrick J; Quitkin Frederic M
Do age of onset and course of illness define biologically distinct groups within atypical depression?
Journal of abnormal psychology 2003;112(2):253-62.
2003: Quitkin Frederic M; Petkova Eva; McGrath Patrick J; Taylor Bonnie; Beasley Charles; Stewart Jonathan; Amsterdam Jay; Fava Maurizio; Rosenbaum Jerrold; Reimherr Frederick; Fawcett Jan; Chen Ying; Klein Donald
When should a trial of fluoxetine for major depression be declared failed?
The American journal of psychiatry 2003;160(4):734-40.
2002: Quitkin Frederic M; Stewart Jonathan W; McGrath Patrick J; Taylor Bonnie P; Tisminetzky Mayra S; Petkova Eva; Chen Ying; Ma Guoguang; Klein Donald F
Are there differences between women's and men's antidepressant responses?
The American journal of psychiatry 2002;159(11):1848-54.
2002: Agosti V; Quitkin F M; Stewart J W; McGrath P J
Somatization as a predictor of medication discontinuation due to adverse events.
International clinical psychopharmacology 2002;17(6):311-4.
2002: Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Ma Guoguang Julie; Wexler Bruce E; Quitkin Frederic M
Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces.
Journal of abnormal psychology 2002;111(3):446-54.
2002: Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M
Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):237-45.
2001: Bruder G E; Stewart J W; Tenke C E; McGrath P J; Leite P; Bhattacharya N; Quitkin F M
Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant.
Biological psychiatry 2001;49(5):416-25.
2000: McGrath P J; Nunes E V; Quitkin F M
Current concepts in the treatment of depression in alcohol-dependent patients.
The Psychiatric clinics of North America 2000;23(4):695-711, V.
2000: McGrath P J; Stewart J W; Petkova E; Quitkin F M; Amsterdam J D; Fawcett J; Reimherr F W; Rosenbaum J F; Beasley C M
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.
The Journal of clinical psychiatry 2000;61(7):518-24.
2000: Petkova E; Quitkin F M; McGrath P J; Stewart J W; Klein D F
A method to quantify rater bias in antidepressant trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(6):559-65.
2000: McGrath P J; Stewart J W; Janal M N; Petkova E; Quitkin F M; Klein D F
A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
The American journal of psychiatry 2000;157(3):344-50.
1999: Stewart J W; Quitkin F M; McGrath P J; Bruder G E
Do tricyclic responders have different brain laterality?
Journal of abnormal psychology 1999;108(4):707-10.
1998: Quitkin F M; McGrath P J; Stewart J W; Ocepek-Welikson K; Taylor B P; Nunes E; Delivannides D; Agosti V; Donovan S J; Ross D; Petkova E; Klein D F
Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications.
The British journal of psychiatry : the journal of mental science 1998;173():242-8.
1998: Stewart J W; Quitkin F M; McGrath P J; Amsterdam J; Fava M; Fawcett J; Reimherr F; Rosenbaum J; Beasley C; Roback P
Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo.
Archives of general psychiatry 1998;55(4):334-43.
1998: Nunes E V; Quitkin F M; Donovan S J; Deliyannides D; Ocepek-Welikson K; Koenig T; Brady R; McGrath P J; Woody G
Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.
Archives of general psychiatry 1998;55(2):153-60.
1998: Bruder G E; Tenke C E; Towey J P; Leite P; Fong R; Stewart J E; McGrath P J; Quitkin F M
Brain ERPs of depressed patients to complex tones in an oddball task: relation of reduced P3 asymmetry to physical anhedonia.
Psychophysiology 1998;35(1):54-63.
1997: Bruder G E; Fong R; Tenke C E; Leite P; Towey J P; Stewart J E; McGrath P J; Quitkin F M
Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study.
Biological psychiatry 1997;41(9):939-48.
1996: Quitkin F M; McGrath P J; Stewart J W; Taylor B P; Klein D F
Can the effects of antidepressants be observed in the first two weeks of treatment?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):390-4.
1996: Quitkin F M; McGrath P J; Stewart J W; Ocepek-Welikson K; Taylor B P; Nunes E; Deliyannides D; Agosti V; Donovan S J; Petkova E; Klein D F
Chronological milestones to guide drug change. When should clinicians switch antidepressants?
Archives of general psychiatry 1996;53(9):785-92.
1996: Bruder G E; Otto M W; McGrath P J; Stewart J W; Fava M; Rosenbaum J F; Quitkin F M
Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(2):171-9.
1996: Nunes E V; Deliyannides D; Donovan S; McGrath P J
The management of treatment resistance in depressed patients with substance use disorders.
The Psychiatric clinics of North America 1996;19(2):311-27.
1996: McGrath P J; Nunes E V; Stewart J W; Goldman D; Agosti V; Ocepek-Welikson K; Quitkin F M
Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial.
Archives of general psychiatry 1996;53(3):232-40.
1995: Nunes E V; McGrath P J; Quitkin F M; Ocepek-Welikson K; Stewart J W; Koenig T; Wager S; Klein D F
Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
Drug and alcohol dependence 1995;39(3):185-95.
1995: Nunes E V; McGrath P J; Quitkin F M
Treating anxiety in patients with alcoholism.
The Journal of clinical psychiatry 1995;56 Suppl 2():3-9.
1994: McGrath P J; Stewart J W; Quitkin F M; Wager S; Jenkins S W; Archibald D G; Stringfellow J C; Robinson D S
Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
Journal of clinical psychopharmacology 1994;14(5):347-52.
1994: McGrath P J; Stewart J W; Nunes E N; Quitkin F M
Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
The Journal of clinical psychiatry 1994;55(8):336-9.
1994: Goldman R G; Skodol A E; McGrath P J; Oldham J M
Relationship between the Tridimensional Personality Questionnaire and DSM-III-R personality traits.
The American journal of psychiatry 1994;151(2):274-6.
1994: Donovan S J; Quitkin F M; Stewart J W; Ocepek-Welikson K; Harrison W; McGrath P J; Nunes E V; Wager S; Tricamo E
Duration of antidepressant trials: clinical and research implications.
Journal of clinical psychopharmacology 1994;14(1):64-6.
1994: Rothschild R; Quitkin H M; Quitkin F M; Stewart J W; Ocepek-Welikson K; McGrath P J; Tricamo E
A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
The International journal of eating disorders 1994;15(1):1-9.
1993: Stewart J W; McGrath P J; Quitkin F M; Rabkin J G; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
Chronic depression: response to placebo, imipramine, and phenelzine.
Journal of clinical psychopharmacology 1993;13(6):391-6.
1993: Stewart J W; McGrath P J; Rabkin J G; Quitkin F M
Atypical depression. A valid clinical entity?
The Psychiatric clinics of North America 1993;16(3):479-95.
1993: Quitkin F M; Stewart J W; McGrath P J; Tricamo E; Rabkin J G; Ocepek-Welikson K; Nunes E; Harrison W; Klein D F
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
The British journal of psychiatry. Supplement 1993;(21):30-4.
1993: Nunes E V; McGrath P J; Quitkin F M; Stewart J P; Harrison W; Tricamo E; Ocepek-Welikson K
Imipramine treatment of alcoholism with comorbid depression.
The American journal of psychiatry 1993;150(6):963-5.
1993: McGrath P J; Stewart J W; Tricamo E; Nunes E N; Quitkin F M
Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
Journal of clinical psychopharmacology 1993;13(3):224-5.
1993: Quitkin F M; Stewart J W; McGrath P J; Nunes E; Ocepek-Welikson K; Tricamo E; Rabkin J G; Klein D F
Further evidence that a placebo response to antidepressants can be identified.
The American journal of psychiatry 1993;150(4):566-70.
1993: Quitkin F M; Stewart J W; McGrath P J; Nunes E; Ocepek-Welikson K; Tricamo E; Rabkin J G; Ross D; Klein D F
Loss of drug effects during continuation therapy.
The American journal of psychiatry 1993;150(4):562-5.
1993: McGrath P J; Stewart J W; Nunes E V; Ocepek-Welikson K; Rabkin J G; Quitkin F M; Klein D F
A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
The American journal of psychiatry 1993;150(1):118-23.
1992: McGrath P J; Stewart J W; Harrison W M; Ocepek-Welikson K; Rabkin J G; Nunes E N; Wager S G; Tricamo E; Quitkin F M; Klein D F
Predictive value of symptoms of atypical depression for differential drug treatment outcome.
Journal of clinical psychopharmacology 1992;12(3):197-202.
1992: Stewart J W; McGrath P J; Quitkin F M
Can mildly depressed outpatients with atypical depression benefit from antidepressants?
The American journal of psychiatry 1992;149(5):615-9.
1991: Quitkin F M; Harrison W; Stewart J W; McGrath P J; Tricamo E; Ocepek-Welikson K; Rabkin J G; Wager S G; Nunes E; Klein D F
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
Archives of general psychiatry 1991;48(4):319-23.
1991: Quitkin F M; McGrath P J; Rabkin J G; Stewart J W; Harrison W; Ross D C; Tricamo E; Fleiss J; Markowitz J; Klein D F
Different types of placebo response in patients receiving antidepressants.
The American journal of psychiatry 1991;148(2):197-203.
1991: Quitkin F M; Rabkin J G; Stewart J W; McGrath P J; Harrison W; Ross D C; Tricamo E; Fleiss J; Markowitz J; Klein D F
Heterogeneity of clinical response during placebo treatment.
The American journal of psychiatry 1991;148(2):193-6.
1990: Rabkin J G; McGrath P J; Quitkin F M; Tricamo E; Stewart J W; Klein D F
Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression.
The American journal of psychiatry 1990;147(12):1622-6.
1990: Quitkin F M; McGrath P J; Stewart J W; Harrison W; Tricamo E; Wager S G; Ocepek-Welikson K; Nunes E; Rabkin J G; Klein D F
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
Archives of general psychiatry 1990;47(10):935-41.
1990: Nunes E V; McGrath P J; Wager S; Quitkin F M
Lithium treatment for cocaine abusers with bipolar spectrum disorders.
The American journal of psychiatry 1990;147(5):655-7.
1989: Stewart J W; McGrath P J; Quitkin F M; Harrison W; Markowitz J; Wager S; Leibowitz M R
Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
Archives of general psychiatry 1989;46(12):1080-7.
1989: Quitkin F M; McGrath P J; Stewart J W; Harrison W; Wager S G; Nunes E; Rabkin J G; Tricamo E; Markowitz J; Klein D F
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
Archives of general psychiatry 1989;46(9):787-93.
1989: Terman M; Terman J S; Quitkin F M; McGrath P J; Stewart J W; Rafferty B
Light therapy for seasonal affective disorder. A review of efficacy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(1):1-22.
1989: Harrison W M; McGrath P J; Stewart J W; Quitkin F
MAOIs and hypertensive crises: the role of OTC drugs.
The Journal of clinical psychiatry 1989;50(2):64-5.
1989: Parsons B; Quitkin F M; McGrath P J; Stewart J W; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin J G; Wager S G; Nunes E
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
Psychopharmacology bulletin 1989;25(4):524-34.
1989: McGrath P J; Stewart J W; Harrison W; Wager S; Nunes E N; Quitkin F M
A placebo-controlled trial of L-deprenyl in atypical depression.
Psychopharmacology bulletin 1989;25(1):63-7.
1988: McGrath P J; Cooper T B; Quitkin F M; Klein D F
Effects of imipramine and phenelzine on plasma PEA levels.
Psychiatry research 1988;26(2):239.
1988: Stewart J W; Quitkin F M; McGrath P J; Rabkin J G; Markowitz J S; Tricamo E; Klein D F
Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
Psychiatry research 1988;25(2):213-22.
1988: McGrath P J; Stewart J W; Liebowitz M R; Markowitz J M; Quitkin F M; Klein D F; Gorman J M
Lactate provocation of panic attacks in depressed outpatients.
Psychiatry research 1988;25(1):41-7.
1988: Agosti V; Stewart J W; Quitkin F M; Rabkin J G; McGrath P J; Markowitz J
Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.
The Journal of clinical psychiatry 1988;49(5):196-8.
1988: Quitkin F M; Stewart J W; McGrath P J; Liebowitz M R; Harrison W M; Tricamo E; Klein D F; Rabkin J G; Markowitz J S; Wager S G
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
The American journal of psychiatry 1988;145(3):306-11.
1988: Liebowitz M R; Quitkin F M; Stewart J W; McGrath P J; Harrison W M; Markowitz J S; Rabkin J G; Tricamo E; Goetz D M; Klein D F
Antidepressant specificity in atypical depression.
Archives of general psychiatry 1988;45(2):129-37.
1988: Terman M; Terman J S; Quitkin F M; Cooper T B; Lo E S; Gorman J M; Stewart J W; McGrath P J
Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder. Short note.
Journal of neural transmission 1988;72(2):147-65.
1987: McGrath P J; Blood D K; Stewart J W; Harrison W; Quitkin F M; Tricamo E; Markowitz J
A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo.
Journal of clinical psychopharmacology 1987;7(5):335-9.
1987: Terman M; Quitkin F M; Terman J S; Stewart J W; McGrath P J
The timing of phototherapy: effects on clinical response and the melatonin cycle.
Psychopharmacology bulletin 1987;23(3):354-7.
1987: Markowitz J S; Rabkin J G; Stewart J; Tricamo E; McGrath P J; Harrison W; Ocepek-Welikson K; Quitkin F M
Validity assessment of SAFTEE: a preliminary report.
Psychopharmacology bulletin 1987;23(1):102-5.
1986: Harrison W M; Rabkin J G; Ehrhardt A A; Stewart J W; McGrath P J; Ross D; Quitkin F M
Effects of antidepressant medication on sexual function: a controlled study.
Journal of clinical psychopharmacology 1986;6(3):144-9.
1984: Harrison W M; Cooper T B; Stewart J W; Quitkin F M; McGrath P J; Liebowitz M R; Rabkin J R; Markowitz J S; Klein D F
The tyramine challenge test as a marker for melancholia.
Archives of general psychiatry 1984;41(7):681-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Patrick McGrath

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Devices

Procedures

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Patrick McGrath (preview)

All Publications